Hepatitis A in Latin America: a changing epidemiologic pattern
- PMID: 10586919
- DOI: 10.4269/ajtmh.1999.61.825
Hepatitis A in Latin America: a changing epidemiologic pattern
Abstract
In a multicenter study, hepatitis A virus (HAV) seroprevalence was surveyed in six countries in Latin America in which in 12,000 subjects were stratified for age. The highest rates of seroprevalence were recorded in the Dominican Republic (89.0%) and Mexico (81.0%), with lower rates in Brazil (64.7%), Chile (58.1%), Venezuela (55.7%), and Argentina (55.0%). The seroprevalence of HAV in children between 1 and 5 years of age was less than 50%, except in the Dominican Republic. In the 5-10-year-old age group, seroprevalence rates have also decreased compared with previous reports. This suggests that the epidemiology is shifting from high to intermediate endemicity, with the population susceptible to HAV infection shifting from children to adolescents and adults. Furthermore, data from Brazil, Argentina, and Mexico show that HAV seroprevalence is significantly lower in people living in medium and high socioeconomic conditions. This study suggests the need for appropriate vaccination programs to be implemented targeting children, adolescents, and adults, particularly in higher socioeconomic groups.
Similar articles
-
Hepatitis A shifting epidemiology in Latin America.Vaccine. 2000 Feb 18;18 Suppl 1:S57-60. doi: 10.1016/s0264-410x(99)00466-1. Vaccine. 2000. PMID: 10683550
-
[Hepatitis A and hepatitis B seroprevalence in 4 centers in Brazil].Rev Soc Bras Med Trop. 2000 Jan-Feb;33(1):1-10. doi: 10.1590/s0037-86822000000100001. Rev Soc Bras Med Trop. 2000. PMID: 10881112 Portuguese.
-
Hepatitis A shifting epidemiology in the Middle East and Africa.Vaccine. 2000 Feb 18;18 Suppl 1:S65-7. doi: 10.1016/s0264-410x(99)00468-5. Vaccine. 2000. PMID: 10683552
-
Hepatitis A in Latin America: The current scenario.Rev Med Virol. 2024 Jul;34(4):e2566. doi: 10.1002/rmv.2566. Rev Med Virol. 2024. PMID: 38970225 Review.
-
Hepatitis A epidemiology in Latin American countries: a 2020 view from a systematic literature review.Expert Rev Vaccines. 2020 Sep;19(9):795-805. doi: 10.1080/14760584.2020.1813575. Epub 2020 Sep 21. Expert Rev Vaccines. 2020. PMID: 32955965
Cited by
-
Seroprevalence of hepatitis A virus in a cross-sectional study in Mexico: Implications for hepatitis A vaccination.Hum Vaccin Immunother. 2013 Feb;9(2):375-81. doi: 10.4161/hv.22774. Epub 2013 Jan 4. Hum Vaccin Immunother. 2013. PMID: 23291940 Free PMC article.
-
Development and evaluation of a broadly reactive TaqMan assay for rapid detection of hepatitis A virus.Appl Environ Microbiol. 2005 Jun;71(6):3359-63. doi: 10.1128/AEM.71.6.3359-3363.2005. Appl Environ Microbiol. 2005. PMID: 15933042 Free PMC article.
-
Cohort effects in dynamic models and their impact on vaccination programmes: an example from hepatitis A.BMC Infect Dis. 2006 Dec 5;6:174. doi: 10.1186/1471-2334-6-174. BMC Infect Dis. 2006. PMID: 17147828 Free PMC article.
-
Seroprevalence of hepatitis A infection in a low endemicity country: a systematic review.BMC Infect Dis. 2005 Jul 7;5:56. doi: 10.1186/1471-2334-5-56. BMC Infect Dis. 2005. PMID: 16001978 Free PMC article.
-
The cost-effectiveness of universal vaccination of children against hepatitis A in Argentina: results of a dynamic health-economic analysis.J Gastroenterol. 2007 Feb;42(2):152-60. doi: 10.1007/s00535-006-1984-x. Epub 2007 Mar 12. J Gastroenterol. 2007. PMID: 17351805
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical